Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma
Clinical trial NCT01755975 · COMPLETED
Trial details
- NCT number
- NCT01755975
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2023-10-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.